Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver 2019 April 10-14 Vienna Austria Back

Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvirfor six weeks among people with acute and recent HCV infection       Reported by Jules Levin EASL 2019 April 10-14 Vienna